Discrepancies in addressing overdose prevention through prescription monitoring programs

被引:11
|
作者
Green, Traci C. [1 ,3 ]
Bowman, Sarah [1 ]
Davis, Corey [2 ]
Los, Cristina [1 ]
McHugh, Kimberly [1 ]
Friedmann, Peter D. [3 ]
机构
[1] Inflexxion Inc, Newton, MA 02464 USA
[2] Network Publ Hlth Law, Carrboro, NC 27510 USA
[3] Rhode Isl Hosp, Providence, RI 02903 USA
关键词
Overdose; Prescription monitoring programs; Prescription opioids; Drug policy; Unintentional poisoning; HEROIN USERS; DISTRIBUTING NALOXONE; COST-EFFECTIVENESS; DRUG OVERDOSE; IMPLEMENTATION; PHYSICIANS; REVERSAL; IMPACT; RATES; HELP;
D O I
10.1016/j.drugalcdep.2015.05.009
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background: State prescription monitoring programs (PMPs) purport to address the prescription opioid epidemic, but have evidenced limited effect on reducing opioid-related mortality. Methods: We systematically reviewed publicly available, PMP web-based materials from December, 2012 to October, 2013, to assess the degree to which overdose prevention was articulated in state PMP goals, mission statement, and accessible educational materials. The sites and available resources of 47 state PMPs with a web presence were reviewed by two independent coders for use of "overdose" and related terms. Website materials were further coded to capture five general thematic orientations: supply reduction-therapeutic, supply reduction-punitive, demand reduction, public health/research, and harm reduction oriented in content. Results: Twenty-nine of 47 (62%) PMPs did not address overdose or related terms in available online materials; six (12.8%) contained overdose-oriented messaging; and two included specific overdose prevention tools for providers. There were a median of three thematic orientations represented on the 18 state PMP websites mentioning only the term overdose, compared with a median of 4.5 thematic domains on the six PMP websites with overdose-oriented content. Conclusions: A more comprehensive, public health orientation for PMPs that explicitly and publicly articulates their application and role in overdose prevention may increase PMP effectiveness and use. (C) 2015 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:355 / 358
页数:4
相关论文
共 50 条
  • [41] Mandatory Access Prescription Drug Monitoring Programs and Prescription Drug Abuse
    Grecu, Anca M.
    Dave, Dhaval M.
    Saffer, Henry
    [J]. JOURNAL OF POLICY ANALYSIS AND MANAGEMENT, 2019, 38 (01) : 181 - +
  • [42] Opioid overdose prevention through pharmacy-based naloxone prescription program: Innovations in health care delivery
    Bachyrycz, Amy
    Shrestha, Shikhar
    Bleske, Barry E.
    Tinker, Dale
    Bakhireva, Ludmila N.
    [J]. SUBSTANCE ABUSE, 2017, 38 (01) : 55 - 60
  • [43] Virtual overdose monitoring services: a novel adjunctive harm reduction approach for addressing the overdose crisis
    Matskiv, George
    Marshall, Tyler
    Krieg, Oona
    Viste, Dylan
    Ghosh, S. Monty
    [J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 2022, 194 (46) : E1568 - E1572
  • [44] Prevention of Prescription Opioid Misuse and Projected Overdose Deaths in the United States
    Chen, Qiushi
    Larochelle, Marc R.
    Weaver, Davis T.
    Lietz, Anna P.
    Mueller, Peter P.
    Mercaldo, Sarah
    Wakeman, Sarah E.
    Freedberg, Kenneth A.
    Raphel, Tiana J.
    Knudsen, Amy B.
    Pandharipande, Pari V.
    Chhatwal, Jagpreet
    [J]. JAMA NETWORK OPEN, 2019, 2 (02) : e187621
  • [45] OB/GYN perceptions of prescription drug monitoring programs as a primary prevention tool for neonatal abstinence syndrome
    Brown, Joshua D.
    Delcher, P. Chris
    Bae, Jungjun
    Roussos-Ross, Dikea
    Goodin, Amie J.
    [J]. RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY, 2020, 16 (12): : 1789 - 1791
  • [46] Surveillance, Self-Governance, and Mortality: The Impact of Prescription Drug Monitoring Programs on US Overdose Mortality, 2000-2016
    Vuolo, Mike
    Frizzell, Laura C.
    Kelly, Brian C.
    [J]. JOURNAL OF HEALTH AND SOCIAL BEHAVIOR, 2022, 63 (03) : 337 - 356
  • [48] Regulating opioid prescribing through prescription monitoring programs: Balancing drug diversion and treatment of pain
    Fishman, SM
    Papazian, JS
    Gonzalez, S
    Riches, PS
    Gilson, A
    [J]. PAIN MEDICINE, 2004, 5 (03) : 309 - 324
  • [49] Prescription drug monitoring programs use mandates and prescription stimulant and depressant quantities
    Gunadi, Christian
    Shi, Yuyan
    [J]. BMC PUBLIC HEALTH, 2023, 23 (01)
  • [50] Prescription drug monitoring programs use mandates and prescription stimulant and depressant quantities
    Christian Gunadi
    Yuyan Shi
    [J]. BMC Public Health, 23